Giuseppe Stragliotto | Virus | Innovative Research Award

Innovative Research Award

Giuseppe Stragliotto
Karolinska University Hospital, Stockholm

Giuseppe Stragliotto
Affiliation Karolinska University Hospital, Stockholm
Country Sweden
Scopus ID 6602379408
Documents 31
Citations 3306
h-index 18
Subject Area Virus
Event International Research Awards on Infectious Diseases
ORCID 0000-0003-1968-6447

The Innovative Research Award recognizes sustained scientific contributions that advance knowledge in virology and infectious disease research. Giuseppe Stragliotto has established an academic profile through peer-reviewed publications, collaborative investigations, and measurable scholarly impact. His research activities have contributed to scientific understanding within the field of virus-related medicine while supporting evidence-based clinical and translational research initiatives.[1]

Abstract

Giuseppe Stragliotto is recognized for sustained scientific contributions in virology and infectious disease research through clinical investigation, multidisciplinary collaboration, and scholarly publication. His documented research output demonstrates consistent engagement with virus-related studies, supporting advances in diagnosis, treatment strategies, and evidence-based medical practice. Citation metrics, publication productivity, and international visibility indicate measurable academic influence within the scientific community. These achievements provide a strong foundation for consideration for the Innovative Research Award, reflecting professional excellence, continued research commitment, and meaningful contributions to advancing infectious disease knowledge and improving future healthcare research initiatives worldwide.[1]

Keywords

Virus, Virology, Infectious Diseases, Clinical Research, Translational Medicine, Medical Science, Scholarly Publications, Research Impact, Academic Excellence, Innovation.

Introduction

Innovation in infectious disease research supports improved understanding of viral mechanisms, patient management, and future healthcare solutions. Academic recognition highlights researchers whose published work demonstrates scientific quality, collaborative engagement, and measurable influence across international research communities through peer-reviewed evidence and responsible scientific practice.[2]

Research Profile

Giuseppe Stragliotto is affiliated with Karolinska University Hospital, Stockholm, Sweden. His Scopus profile records thirty-one indexed publications with more than three thousand citations and an h-index of eighteen, reflecting sustained scholarly productivity and recognized influence within virus-related biomedical research.[1]

Research Contributions

Research contributions emphasize virology, infectious diseases, interdisciplinary collaboration, and clinically relevant investigations. Published studies have supported scientific understanding through evidence-based methodologies, encouraging knowledge dissemination while strengthening the connection between laboratory discoveries and practical healthcare applications across international scientific networks.[3]

Publications

The documented publication portfolio demonstrates continuous participation in peer-reviewed scientific literature. Indexed articles contribute to the visibility of virus research and provide accessible evidence for clinicians, researchers, and academic institutions seeking reliable scientific findings within infectious disease investigations.[1]

Research Impact

Citation performance and bibliometric indicators demonstrate broad scholarly recognition. More than three thousand citations and an h-index of eighteen indicate that published research has influenced subsequent scientific investigations, supporting continued advancement of virology and infectious disease research through widely referenced academic contributions.[1]

Award Suitability

The documented academic profile demonstrates characteristics commonly associated with research excellence, including peer-reviewed productivity, measurable citation impact, international collaboration, and continued engagement in virus research. These factors support consideration for the Innovative Research Award using transparent scholarly evaluation criteria.[2]

Conclusion

Giuseppe Stragliotto’s documented scholarly achievements illustrate consistent scientific engagement and measurable academic influence. His publication record, citation performance, and contributions to virus research represent a professional research profile appropriate for recognition within international academic award programs dedicated to infectious disease research.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Giuseppe Stragliotto, Author ID 6602379408. Scopus.
    https://www.scopus.com/pages/authors/6602379408
  2. ORCID. (n.d.). Researcher Profile: Giuseppe Stragliotto.
    https://orcid.org/0000-0003-1968-6447
  3. Pantalone, M. R., Stragliotto, G., Martin-Almazan, N., Peredo-Harvey, I., Jimenez-Macias, J. L., Rahbar, A., Lawler, S., Bartek, J., & Söderberg-Naucler, C. (n.d.). Valganciclovir therapy prevents human cytomegalovirus reactivation in glioblastoma patients undergoing radiochemotherapy and extends time to tumor progression.
    https://www.mdpi.com/2072-6694/18/10/1575

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Wenzhou Sixth People’s Hospital | China.

Author Profile

Scopus

🎓Education

Master’s Degree – Wenzhou Medical College

đź’ĽProfessional Experience

Mr. Jiang has held several key leadership positions in the healthcare sector. He serves as the Deputy Secretary of the Party Committee at Wenzhou Central Hospital and previously led as the President of the Sixth People’s Hospital of Wenzhou. During the COVID-19 pandemic, he played a critical role as the Leader of the COVID-19 Treatment Team in Wenzhou, ensuring effective patient care and outbreak control. Additionally, he led the Wenzhou Medical Team in Shanghai, where he also served as the Temporary Party Branch Secretary, overseeing medical operations and emergency response efforts.

📚Academic Contributions

Mr. Jiang has made significant contributions to medical research, with 17+ SCI-indexed publications and over 30 articles in Chinese medical journals. He has also served as an editor of two medical books, further advancing knowledge in infectious disease management. His research efforts extend to national and provincial projects, where he has played a key role in developing innovative healthcare solutions and public health strategies.

🧑‍🔬Technical Skills 

Mr. Xiangao Jiang possesses advanced expertise in infectious disease diagnosis and treatment, specializing in managing hepatitis, chronic liver diseases, tuberculosis, and other critical infections. His proficiency extends to critical care management, where he has played a key role in handling complex and severe infectious disease cases. Additionally, his strong leadership in medical administration and public health response has been demonstrated through his roles in hospital management, pandemic control, and policy implementation, ensuring effective healthcare delivery and crisis management.

📚Teaching Experience

Tutor for postgraduate students at Wenzhou Medical University & Shanghai University

🏆Awards and Honors

Mr. Jiang’s outstanding contributions to medicine and healthcare have earned him the prestigious titles of Wenzhou Famous Doctor and Ou Yue Famous Doctor. His leadership and expertise have also been recognized through his selection as a Health Leading Talent under Zhejiang Province’s “Ten Thousand People Plan”, a distinction awarded to top professionals making significant impacts in their fields.

🔬Research Interests

Mr. Jiang’s research focuses on hepatitis and chronic liver diseases, with an emphasis on understanding disease progression and developing effective treatment strategies. He is also deeply engaged in infectious disease epidemiology, studying patterns and risk factors to enhance prevention and control measures. Additionally, his work in public health and outbreak management has contributed to improving emergency response strategies and healthcare policies, particularly in the face of emerging infectious threats.

📑Notable Publications 

‘Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China’
Authors: C. Qiu, Chaochao; X. Lin, Xiaoqing; Q. Zhang, Qiang; J. Shi, Jichan; X. Jiang, Xiangao
Year: 2025
Journal: BMC Infectious Diseases

‘Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus’
Authors: L. Wu, Lianpeng; N. Chen, Na; D. Xia, Dandan; X. Jiang, Xiangao
Year: 2025
Journal: Frontiers in Medicine

 ‘Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysisy’
Authors: X. Cai, Xiaoxiao; X. Xu, Xueqin; G. He, Guiqing; X. Jiang, Xiangao; L. Wu, Lianpeng
Year: 2024
Journal: BMC Infectious Diseases

‘Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China

Authors: G. He, Guiqing; Q. Zheng, Qingyong; J. Wu, Jing; X. Jiang, Xiangao; X. Yu, Xia
Year: 2024
Journal: Microbiology Spectrum